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Summary
Maintenance of body temperature is essential for survival of homeotherms. Brown adipose tissue
(BAT) is a specialized fat tissue that is dedicated to thermoregulation1. Due to its remarkable
capacity to dissipate stored energy and its demonstrated presence in adult humans2-5, BAT holds
great promise for the treatment of obesity and metabolic syndrome1. Rodent data suggest the
existence of two types of brown fat cells: the constitutive BAT (cBAT), which is of embryonic
origin and anatomically located in the interscapular region of mice, and the recruitable BAT
(rBAT) that resides within white adipose tissue (WAT)6 and skeletal muscle7, that has
alternatively been called beige8, brite9, or inducible BAT10. Bone morphogenetic proteins (BMPs)
regulate the formation and thermogenic activity of BAT10-12. We here provide evidence for a
systemically active regulatory mechanism that serves to control whole body BAT-activity for
thermoregulation and energy homeostasis. Genetic ablation of type 1A BMP-receptor (Bmpr1A)
in brown adipogenic progenitor cells leads to a severe paucity of cBAT. This in turn increases
sympathetic input to WAT, thereby promoting the formation of rBAT within white fat depots.
This previously unknown compensatory mechanism, aimed at restoring total brown fat-mediated
thermogenic capacity in the body, is sufficient to maintain normal temperature homeostasis and
resistance to diet-induced obesity. These data suggest an important physiological cross-talk
between the constitutive and recruitable brown fat cells. This sophisticated regulatory mechanism
of body temperature may participate in the control of energy balance and metabolic disease.
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It has recently become clear that cBAT shares a common developmental ancestry with
skeletal muscle13,14, whereas rBAT, localized within white fat or skeletal muscle, derives
from a non-myogenic lineage10,13. Lineage-tracing experiments have also revealed that
cBAT arises from progenitors located in the embryonic dermomyotome15 that express
myogenic markers Pax7 and Myf513,16. We thus generated a mouse model lacking
BMPR1A in all cells descending from the Myf5pos lineage (Myf5-BMPR1A-KO). No
apparent changes in morphology, proliferation, or apoptosis were observed during early
embryonic stages (Supplementary Fig. 1 and 2). Histological evidence of reduced cBAT-
formation in Myf5-BMPR1A-KO mice was first observed at embryonic day 16.5 (E16.5)
and persisted until after birth (P1, Fig. 1a-c). cBAT arises from highly proliferative
fibroblasts during late gestational stages17. At E16.5, developing cBAT stains strongly for
the proliferation marker Ki67, which was markedly decreased in Myf5-BMPR1A-KO
embryos (Fig. 1d, Supplementary Fig. 2b and 2d). Apoptosis-levels were found unchanged
throughout embryogenesis Supplementary Fig. 2c), suggesting that reduced proliferation
occurring prior to or around E16.5 is responsible for defective formation of cBAT in KO
animals.
Myf5-BMPR1A-KO mice were born runted and stayed smaller throughout life (Fig. 1e and
1f). Importantly, the reduction of cBAT mass remained highly significant in adult mice (Fig.
1g and 1h). Despite this, gene expression pattern of the residual cBAT appeared normal,
apart from a moderate reduction of Bmpr1A gene expression (Supplementary Fig.3). The
sizes of interscapular WAT (iWAT) and retroperitoneal WAT (rWAT), two white fat depots
that contain subpopulations of cells from the Myf5pos lineage18, were also reduced in the
KO-mice (Supplementary Fig. 4a). Gene expression in iWAT showed a trend towards
reduced expression of BAT-genes, but no changes in general white adipogenic genes
(Supplementary Fig. 4b). Subcutaneous WAT (sWAT) and epididymal WAT (eWAT), both
mostly originating from a Myf5neg lineage18, were not decreased in size and expressed
normal levels of all type-I BMP receptors (Fig. 1g-h, Supplementary Fig. 3a-c). Expression
of Bmpr1A in skeletal muscle, on the other hand, was reduced by >95% (Supplementary
Fig. 3a). Upon normalization to body weight, we found limb skeletal muscle size
unchanged, while the function of myogenic progenitors was altered (Huang and Gussoni,
unpublished data). Thus, loss of BMP-signaling in Myf5-expressing cells specifically targets
the formation of cBAT. During embryogenesis, MyoDpos progenitors emerge after the
Myf5pos progenitors19. MyoD-CRE driven Bmpr1A-KO mice showed completely normal
development of cBAT and WAT depots (Supplementary Fig. 5), suggesting that the
developmental divergence between myogenic and brown adipogenic progenitors takes place
prior to emergence of MyoDpos progenitors, or that BMPR1A is not required for cBAT-
formation during this particular developmental stage.
A very similar phenotype was observed in a second mouse model with conditional deletion
of Bmpr1A in all types of adipocytes (aP2-BMPR1A-KO). Loss of Bmpr1A led to a specific
paucity of cBAT as well as WAT-resident rBAT (Supplementary Fig. 6). Since the aP2-
CRE driver is active at later adipogenic stages compared to Myf5-CRE, we conclude that
signaling through BMPR1A is essential also for later stages of brown adipogenesis.
Next, we isolated progenitors from either Myf5neg sWAT or Myf5pos cBAT to test their cell-
autonomous ability to produce brown adipocytes10. Cells derived from sWAT differentiated
normally (Supplementary Fig. 7). In contrast, the frequency and ability of cBAT-derived
Myf5pos/Sca1pos/CD31neg progenitors to differentiate into mature brown adipocytes was
significantly reduced (Fig. 2a and 2b). We therefore generated brown pre-adipocytes from
cBAT completely lacking BMPR1A (Supplementary Fig. 8a and 8b). Loss of Bmpr1A
resulted in a marked inhibition of differentiation (Fig. 2c) and ability to respond to BMP7-
induced phosphorylation of downstream targets of BMP-signaling, Smad and p38-mitogen
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activated protein kinase (p38MAPK)20 (Fig. 2d). This led to a concomitant decrease of the
expression of key adipogenic transcription factors Zfp42321, Cebpα, and Pparγ22 in
undifferentiated pre-adipocytes (Fig. 2e). Following adipogenic differentiation, BMPR1A-
KO cells displayed severely reduced expression of BAT-markers Ucp1, Prdm1613, and
Pparγ (Fig. 2f), even in the presence of BMP7. Aside from BMPR1A, BMPR1B and
Activin A receptor, type 1 (ACVR1) are the other two major type 1 BMP-receptors20. While
cBAT developed normally in whole body BMPR1B-KO-mice (Supplementary Fig. 9a and
9b), deletion of Acvr1 in the Myf5pos lineage resulted in a severe reduction of cBAT mass
(Supplementary Fig. 9c and 9d), indicating that both ACVR1 and BMPR1A are essential for
development of cBAT. Accordingly, pre-adipocytes lacking Acvr1 displayed a somewhat
milder phenotype compared to BMPR1A-deficient cells, while in double knock-out cells,
brown adipogenesis was completely abolished (Supplementary Fig. 8c-g).
Since BAT plays a key role in thermoregulation, one would anticipate that the Myf5-
BMPR1A-KO mice would display reduced body temperature as a consequence of
impairment in cBAT-development. Indeed, newborn Myf5-BMPR1A-KO mice, with their
unfavorable surface-to-volume ratio, showed a significant reduction in body temperature
(Fig. 3a and 3b). This reduction in body temperature was surprisingly no longer present in
adult Myf5-BMPR1A-KO (Fig. 3c, 22°C), suggesting a compensatory mechanism aimed at
restoring thermogenic capacity. Non-shivering thermogenesis is a critical response to
prolonged cold exposure in order to maintain body temperature23. When exposed to acute
and chronic cold challenges, control mice were able to quickly resume normal body
temperature after 48 h of cold, suggesting rapid activation of non-shivering thermogenesis
via cBAT and possibly other short-term measures such as muscle shivering, which are less
pronounced in newborn mice. By contrast, Myf5-BMPR1A-KO mice displayed a reduction
in body temperature after 2 and 48 h of cold exposure, presumably due to the paucity of
cBAT (Fig. 3c, 5°C-2h and -48h), as we did not observe any abnormal behavior, such as
increased shivering, under cold exposure. Despite this, body temperature in Myf5-
BMPR1A-KO mice returned to normal after prolonged cold exposure (i.e. 11 days), strongly
suggesting an adaptive recruitment of rBAT to cope with lower ambient temperatures (Fig.
3c, 5°C-11d). Accordingly, KO-animals displayed a marked increase of UCP1-protein
expression in sWAT (Fig. 3d, Supplementary Fig. 10). This browning-effect could be
further enhanced in sWAT, and induced in eWAT, by administration of the β3-adrenergic
receptor agonist CL316,243, as signified by significantly increased expression of BAT-
markers Ucp1 and Cidea in Myf5-BMPR1A-KO mice (Fig. 3e-h), as well as increased
emergence of multilocular UCP1pos adipocytes in WAT (Fig. 3i and 3j).
Recruitable BAT is sensitive to inductive factors, such as BMP710,11, BMP8b12, fibroblast
growth factor (FGF)2124, and the myokine irisin25, among others. However, gene
expression analysis revealed no changes in any of these (Supplementary Fig. 11), suggesting
that the compensatory browning is not mediated by these factors. Since thermogenesis is
rigorously controlled by the sympathetic nervous system (SNS)26,27, we quantified
sympathetic input to white fat in Myf5-BMPR1A-KO mice. Staining for tyrosine
hydroxylase was significantly increased in sWAT of KO-mice (Fig 3k and 3l). Moreover,
circulating levels of norepinephrine (NE) were also significantly elevated in KO-mice,
suggesting that increased sympathetic input may contribute to the browning of WAT in
Myf5-BMPR1A-KO mice (Fig. 3m). Additionally, cold-exposed Myf5-BMPR1A-KO mice
displayed normal NE-induced thermogenic capacity (Fig. 3n, Supplementary Fig. 12), and
thus possess a sufficient ability to compensate for loss of cBAT. These findings suggest that
both types of brown fat may possess similar capacities for thermoregulation if maximally
stimulated. Whereas cBAT is essential during acute cold challenges, compensatory rBAT in
the KO-mice with severe paucity of cBAT plays a critical role in maintaining normal body
temperature, especially during long-term cold exposure. In accordance with these findings,
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Myf5-BMPR1A-KO animals were resistant to diet-induced obesity, even under obesity-
promoting thermoneutrality conditions, where mice no longer require thermogenesis to
maintain body temperature28 (Supplementary Fig. 13).
To determine whether the effect of compensatory browning is also present in other models
of cBAT-atrophy and independent of genetic intervention that could also affect skeletal
muscle, we surgically interrupted innervation of cBAT in wild-type mice. Denervation of
cBAT resulted in a significant decrease of cBAT size and a 68% reduction of Ucp1
expression in cBAT (p=0.0029; Fig. 4a and 4b). As in Myf5-BMPR1A-KO mice, atrophy of
cBAT resulted in increased recruitment of brown adipocytes in WAT (Fig. 4c-e), thus
reinforcing the notion of a systemic mechanism that regulates total BAT-mediated
thermogenic capacity.
It has been documented before that surgical removal of cBAT causes an activation of the
remaining depots of cBAT29. Here we utilize both genetic and surgically-generated models
of cBAT paucity to demonstrate the existence of a physiological mechanism to ensure
thermoregulation by compensatory browning of WAT. This type of BAT may be more
closely related to that found in adult humans8. The system inducing formation of rBAT
appears to involve cBAT-brain and brain-WAT communication that is mediated, at least in
part, by the SNS. Interestingly, obesity-resistance in mice appears to be mostly related to
browning of white fat, rather than adaptive thermogenesis of cBAT30, altogether suggesting
that rBAT is a key contributor to metabolic health. The findings presented here suggest that
any therapeutic approach involving rBAT must take into account the tight regulation of total
BAT-mediated thermogenic capacity and systemic energy metabolism at both peripheral and
possibly also central levels. Targeting these mechanisms, for instance by modifying BMP-
signaling to regulate BAT mass and activity, could constitute a compelling approach to
develop obesity therapies.
Full Methods
Animals
All animal procedures were approved by the Institutional Animal Use and Care Committee
at Joslin Diabetes Center. Transgenic mice carrying floxed alleles for Alk2/Acvr131, or
Alk3/Bmpr1A32 were used to generate conditional gene deletion mouse models by
intercrossing with either Myf5-33 or aP2/FABP2-driven34 CRE-expression as indicated. For
studies involving Alk6/Bmpr1B-deletion, animals with whole body gene deletion of this
receptor were used35. Myf5-CRE expressing animals were also crossed to Rosa26-YFP
reporter mice (The Jackson Laboratory, Bar Harbor, ME) in addition to the Bmpr1A-flox
alleles for Myf5-lineage-tracing and GFP-labeling of Bmpr1A-deficient cells as described
before10. For genotyping, DNA was isolated from tail tip biopsies by boiling in 0.5 ml 50
mM NaOH for 15 min, followed by neutralization by addition of 50 μl 1M Tris-base (pH
6.8) and thorough vortexing. PCR-genotyping was performed using primers as listed in
Supplementary Table S1. Expected band sizes for Bmpr1A during gel analysis were 180 bp
for the wild type allele and 230 bp for the floxed allele. For recombination analysis of
Bmpr1A-mRNA, expected band sizes were: 396 and 233 bp for the intact and recombined
alleles, respectively, and 178 bp for the control PCR of exons 6 to 7. For Alk2-genotyping,
the PCR product was subsequently digested using the restriction enzyme Bgl-I (New
England Biolabs, Ipswich, MA) at 37°C overnight, yielding a band at 250 bp for wild type
mice, and a double band at 90 bp and 160 bp for floxed alleles (all three bands in
heterozygotes). Expected band sizes for Bmpr1B were 350 bp for the wild type, and 300 bp
for the null allele. Expected band sizes for the Rosa26-YFP reporter mice were 600 bp for
the wild type allele and 320 bp for the mutant allele. For Myf5-CRE genotyping, bands at
600 and 400 bp for wild type and mutant alleles, respectively, were expected. For a general
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CRE-PCR, a single band at approximately 350 bp indicated presence of CRE-cDNA in the
genome. For loading control, IRS-1 primers were added for co-amplification in the same
reaction (band at approximately 500 bp) to ensure proper loading with template DNA. To
stimulate the browning of white adipose depots, mice were treated with daily i.p. injections
of 1 mg/kg bodyweight CL316,243 (Sigma-Aldrich, St. Louis, MO) dissolved in PBS (also
used for control injections) for up to ten days. For experiments involving high fat diet
feeding, 4- to 6-week-old animals were placed on a diet containing 45 or 60 kcal% fat
(Research Diets, New Brunswick, NJ). For cold exposure and thermoneutral conditions,
animals were housed at 5°C or 30°C, respectively, for the indicated times in a controlled
environmental chamber (Caron Products & Services Inc., Marietta, OH) with free access to
food and water. Body core temperature was determined by rectal probe measurements.
Haematoxylin & Eosin staining
Sections were prepared, processed, and stained as described11.
Immunofluorescence
Sections were deparaffinized and prepared as described before11. Primary antibodies were
incubated overnight at 4°C: Ki67 (1:200, rabbit polyclonal; Abcam, Cambridge, MA);
UCP1 (1:50, rabbit polyclonal; AnaSpec, Fremont, CA), Tyrosine hydroxylase (1:50, rabbit
polyclonal, Millipore, Billerica, MA), GFP (1:200, goat polyclonal; Novus USA, Littleton,
CO). After primary antibody incubation, the sections were washed and incubated with
appropriate secondary antibody (AlexaFlour-488 (green) or -594 (red); Invitrogen, Carlsbad,
CA) at a 1:200 dilution for 10 min in the dark. After secondary antibody incubation, sections
were washed with distilled water for DAPI-staining (0.1 μg/ml in water for 5-10 minutes in
the dark), and mounted. Sections were kept in the dark after mounting and analyzed by
confocal microscopy on a Zeiss LSM-410 Invert Laser Scan Microscope (Carl Zeiss
MicroImaging, Thornwood, NY), or using a florescence microscope (Olympus BX60F-3;
Olympus Corporation, Center Valley, PA). Quantification of tyrosine hydroxylase was
performed by using the ImageJ software (ImageJ, NIH, Bethesda, MD). Identical conditions
and settings were used for picture acquisition and analysis. A threshold was set for each
image to eliminate background and to create a binary mode image. A minimum particle size
of 20 pixels was used as exclusion criteria to eliminate unspecific background and for
quantification of areas that stained positive for tyrosine hydroxylase. For quantification of
Ki67-staining, Ki67pos nuclei were counted in areas identified as BAT by microscopic
inspection of morphology and comparison to published sources36, and normalized to the
total number of DAPIpos nuclei in the same area. For each section and animal, images from
three representative areas were analyzed.
TUNEL staining
For detection of DNA fragmentation, sections were deparaffinized and blocked for
autofluorescence as described10. Sections were blocked in 1% BSA/ 0.5%-1% TX-100 in
PBS for 1 h followed by washes in PBS. Terminal strand labeling was performed for 1.5 h at
37° C in TdT-buffer (30 mM Tris-HCL, 140 mM Na-Cacodylate, 1 mM Cobalt(II) chloride,
pH 7.2) in the presence of dATP, biotinylated dUTP, and terminal deoxynucleotidyl
transferase (all from Roche Applied Science, Indianapolis, IN). The reaction was stopped by
immersion in 2× SSC buffer and subsequent incubation with Cy3-labeled streptavidin
(1:200; Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 h in the dark.
Sections were then stained with DAPI, mounted, and analyzed as described above.
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RNA and protein quantification
RNA extraction, cDNA synthesis, and quantitative real-time PCR (qPCR) were performed
as described before11. For qPCR analysis, ct-values <30 were used for gene expression
analysis. Protein detection by western blotting was performed as described before11.
Primary antibodies were incubated overnight at 4°C: phospho-Smad-1/5/8 (1:1000, rabbit
polyclonal), Smad1 (1:1000, rabbit polyclonal), phospho-p38 MAPK (1:1000, rabbit
polyclonal), p38-MAPK (1:1000, rabbit polyclonal) (all from Cell Signaling Technologies,
Danvers, MA), UCP1 (1:500, goat polyclonal; Santa Cruz Biotechnology Inc., Santa Cruz,
CA) and β-Tubulin (1:8000, mouse polyclonal; Sigma-Aldrich). HRP-coupled secondary
antibodies (Cell Signaling Technologies) were used at 1:2000 dilutions at room temperature
for 2 h followed by detection using ECL-system.
Cell Sorting
Sca1pos adipocyte progenitor cells were isolated from constitutive brown adipose tissue
(cBAT) and subcutaneous white adipose tissue (sWAT) of Myf5-BMPR1A-KO mice and
control littermates, and differentiated as described before10.
Immortalized pre-adipocytes
Immortalized cell lines were generated as earlier described37. In brief, cBAT from
individual newborn pups (postnatal day 1 or 2) of homozygous floxed parents for the
respective BMP-receptor was collected and pre-adipocytes were isolated by enzymatic
digestion. Pre-adipocytes were immortalized by infection with SV40-expressing lentivirus
and subsequent selection with puromycin. Stable cell lines were then infected with
adenovirus expressing either GFP (control) or a CRE::GFP fusion construct for in vitro
recombination (Gene Transfer Vector Core, University of Iowa, Iowa City, IA). 48 h post-
infection, GFPpos cells were collected by flow cytometry and expanded for subsequent use
in experiments. DNA was isolated for PCR-analysis to determine full recombination of the
respective receptor gene using the primers as detailed above.
Cell culture
Pre-adipocyte cell lines were cultured as described before11, except that 2% fetal bovine
serum was used during differentiation. BMP7-treatments (3.3 nM) were performed for three
days prior to 48 h of adipogenic induction, followed by a differentiation period of 5 days.
Oil Red O staining was performed as described before11.
Thermal imaging of skin surface temperature
Measurement of skin temperature was performed using a thermal imaging camera (T300
InfraRed Camera; FLIR Systems, Inc., North Billerica, MA). Skin surface temperature of
newborns was analyzed using FLIR Reporter 8.5 software (FLIR Systems, Inc.). Images
were acquired by placing newborn mice of the same litter (P4-P6) in 6-well cell culture
dishes, and 2-3 images of each mouse from different angles were acquired in order to
minimize temperature variations due to different postures of the animal. Software drawing
tools were used to draw a region of interest (ROI) around the entire animal, and average
body surface temperature was calculated using that ROI. For each animal, an average
temperature value of the temperatures from all single images was calculated. These averages
were then used for statistical analysis.
Serum parameters
Serum levels of norepinephrine (NE) were determined using a commercially available
ELISA-kit and according to the manufacturer's instructions (Norepinephrine (Research)
ELISA; IBL-America, Minneapolis, MN). To stabilize norepinephrine, 1 mM EDTA and 4
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mM sodium metabisulfite were added to the serum. Serum was prepared by spinning freshly
collected blood in a cooled centrifuge at 6.000 g for 20 min. The clear supernatant was
collected and stored at −80°C. Samples were analyzed within 12 weeks after collection. To
determine circulating irisin levels, a commercially available ELISA assay kit was used
according to the manufacturer's specifications (Phoenix Pharmaceuticals, Inc., Burlingame,
CA).
Body composition
Relative contents of lean and fat mass were determined using Dual-energy X-ray
absorptiometry (DEXA) according to the manufacturer's instructions (GE Lunar PIXImus 2,
General Electric Medical Systems, Pewaukee, WI). Animals were anaesthetized with
pentobarbital (50 mg/kg, i.p.) and placed in the scanning area to measure body composition.
Relative lean and fat mass were calculated by normalizing to body weight.
Norepinephrine-induced thermogenic capacity
Measurement of maximum thermogenic capacity was performed as described before with
some modifications12,28. Animals were maintained in the cold as described above for 8 days
before the experiment. All measurements were performed at room temperature. Oxygen
consumption (OC) by indirect calorimetry was assessed using the Comprehensive Lab
Animal Monitoring System (CLAMS, Columbus Instruments, Columbus, OH) and the
Oxymax for Windows software (version 4.58) for data analysis. Animals were anaesthetized
with pentobarbital (80 mg/kg, i.p.), and indirect calorimetry was performed immediately for
30 min to record basal values of OC. The sampling interval was set to 15 min to allow for
stable OC assessment throughout the experiment. After three data points were obtained,
animals were briefly removed from the chamber and NE was injected subcutaneously (1 mg
norepinephrine bitartrate/kg, Sigma-Aldrich), and OC was recorded for another 90 minutes.
To determine maximum NE-induced thermogenic capacity (ΔVO2), the average value for
basal OC prior to NE-injection was calculated and subtracted from the average value of
highest NE-induced OC (t60 and t75). Areas under the curve (AUC) were calculated for the
curves after NE-injection. Data were presented either not normalized, i.e. per animal, or
after normalization to total body weight, or total fat mass (from DEXA scan).
Denervation of cBAT
Denervation of cBAT was performed as described before38. C57BL/6J mice (The Jackson
Laboratory) aged 6 weeks were used for denervations. In brief, mice were anaesthetized and
placed on a warm pad to maintain body temperature. Under a stereomicroscope, an incision
was made posterior to the interscapular cBAT pad. Surrounding muscle and white fat was
carefully moved to the side and the cBAT pad was turned upward to expose the five
branches of the intercostal nerve bundles. Denervation was performed by isolating and
cutting the nerve bundles and removing a portion of about 1-2 mm from each strand. Care
was taken not to damage the adjacent blood vessels. The procedure was performed on left
and right lobes of the interscapular brown fat. BAT pads, surrounding white fat, and muscle
were placed in the original locations and the incision was closed using tissue adhesive glue
(Vetbond, 3M Animal Care Products, St. Paul, MN). The same procedure was performed for
sham surgeries, except that nerve bundles were not cut. Animals were housed in single cages
and monitored daily during the first week of recovery. After 10 weeks, animals were divided
in four groups of (1) sham-operated mice receiving vehicle i.p.-injections (PBS), (2) sham-
operated mice receiving injections of CL316,243 as described above, (3) denervated mice
receiving vehicle or (4) Cl316,243.
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Statistical analysis
All statistical analyses were performed using the programs Excel (Microsoft Corporation,
Redmond, WA), Statview (SAS Institute Inc., Cary, NC) and GraphPad Prism (GraphPad
Software, Inc, CA). Statistical analyses were performed using two-tailed Student's t-test or
ANOVA for comparing the means of two or multiple groups, respectively. Nonparametric
testing (U-Mann-Whitney test) was used where appropriate, i.e. when normal distribution of
sample sets was not evident. The means of two groups were considered significantly
different when the p-value was smaller than 0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Loss of Bmpr1A impairs cBAT-formation by decreasing embryonic progenitor
proliferation
a, b, H&E-staining of interscapular sections at embryonic stage E16.5 and in newborns (P1).
Photographs (100× original magnification) of the same anatomical location of transversal
sections were acquired for control (CON) and Myf5-BMPR1A-KO mice (KO; § indicates
spinal cord, orange lines indicate brown fat; applies to all panels). c, Macroscopic images of
cBAT of P1-newborns. d, Ki67-immunofluorescence (green) of cBAT at E16.5 and co-
localization with nuclear DAPI-stain (blue, left panels; Analysis of Ki67pos nuclei in
Supplementary Figure 1d), and light microscopy of the same area (right panels, 400×
original magnification). e, f, Body weight analysis of control (C) and Myf5-BMPR1A-KO
(K) mice from P1-newborns (e; n=12/4) and adult mice (f; n=6). g, h, Analysis of cBAT-,
sWAT-, and eWAT-weights after normalization to body weight (n=13). All data are
presented as mean ± s.e.m. Asterisks denote significant differences between genotypes: ** P
< 0.01.
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Figure 2. Ablation of Bmpr1A in brown pre-adipocytes derived from the Myf5pos lineage inhibits
differentiation
a, Relative frequency of Sca1pos/CD31neg/CD11bneg/CD45neg adipogenic progenitors of the
Myf5-CRE(YFP)pos lineage in cBAT after normalization to tissue weight (n=6). White bars
indicate cells isolated from control mice (C), black bars indicate Myf5-BMPR1A-KO cells
(K). b, qPCR analysis of Ucp1, Cell death-inducing DFFA-like effector a (Cidea), and
Bmpr1A mRNAs in FACS-purified primary progenitors from cBAT after adipogenic
differentiation (n=3). Asterisks denote significant differences between genotypes: * P <
0.05. c, Triglyceride-specific Oil Red O staining of differentiated control (C) or BMPR1A-
deficient (K) immortalized pre-adipocyte cell lines pretreated with vehicle (Veh) or BMP7
(B7). d, Western blot of phospho-Smad1/5/8 (1st row), basal Smad1 (2nd row),
corresponding α-Tubulin (3rd row), phospho-p38MAPK (4th row), basal p38MAPK (5th
row), and corresponding α-Tubulin (6th row) in undifferentiated control (CON) and pre-
adipocytes lacking BMPR1A (KO) following exposure to BMP7 for 10, 30, and 60 minutes.
Representative blots from three independent experiments are shown. e, qPCR of zinc-finger
protein 423 (Zfp423), CCAAT/enhancer-binding protein-alpha (Cebpα), and peroxisome
proliferator-activated receptor-gamma (Pparγ) in undifferentiated brown pre-adipocytes
after 24h-exposure to BMP7. f, qPCR of Ucp1, PR-domain-containing-16 (Prdm16), and
Pparγ isolated from mature brown adipocytes. Pre-adipocytes were treated with BMP7 for 3
days, followed by 7-day differentiation. All experiments were performed in triplicate and are
presented as mean ± s.e.m. For panels e and f, statistically significant differences as
determined by ANOVA (p < 0.05) were acontrol (vehicle) vs. control (BMP7); bKO (veh)
vs. KO (BMP7); ccontrol (veh) vs. KO (veh); and dcontrol (BMP7) vs. KO (BMP7).
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Figure 3. Specific ablation of cBAT results in a compensatory response of increased browning by
enhanced sympathetic input to WAT
a, Photographic (left side) and infrared (right side) images of P4-P6 newborns, indicating
KO pups by white circles. b, Quantification of average skin surface temperature from
infrared images. White bars indicate control mice (C), black bars Myf5-BMPR1A-KOs (K;
n=12/10). c, Body core temperature of adult control and Myf5-BMPR1A-KO mice.
Measurements were performed at room temperature (22°C, n=11/10), and following 2 h
(n=5), 48 h (n=7/6), and 11 days (n=7/6) of cold exposure (5°C). d, Western blot analysis of
UCP1 in sWAT and eWAT. e, f, qPCR of Ucp1 gene expression in sWAT (e) and eWAT
(f). Grey bars indicate controls after administration of β3-adrenergic agonist CL316,243 (1
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mg/kg body weight) for ten days, red bars indicate CL316,243-injected Myf5-BMPR1A-KO
(n=7; applies to all panels). g, h, qPCR of Cidea in sWAT (g) and eWAT (h). i, H&E
staining of sWAT and eWAT after administration of CL316,243 (original magnification:
200×). j, UCP1-immunofluorescence (IF) of sWAT and eWAT after administration of
CL316,243 (original magnification: 400×). Left panels show UCP1-IF (green), right panels
show light microscopic image of the same area. k, l, Tyrosine hydroxylase-IF and
quantification of THpos nerve fibers in sWAT after administration of CL316,243 (original
magnification: 400×). (n=3). m, Serum levels of norepinephrine (n=8). n, Time course of
NE-induced oxygen consumption in mice maintained at 5°C for 8 days (control - gray line;
KO - black line; n=5). All data are presented as mean ± s.e.m. Asterisks denote significant
differences between genotypes: * P < 0.05; ** P < 0.01.
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Figure 4. Loss of sympathetic innervation causes atrophy of cBAT and compensatory browning
of white fat
a, Tissue weight of cBAT, sWAT, and eWAT normalized to body weight in sham-operated
mice (S, white bars) and mice after surgical denervation of cBAT (D, black bars). b, c, d,
qPCR of Ucp1 in cBAT (b), sWAT (c), and eWAT (d) of control mice, denervated mice,
controls (S, grey bars) or denervated (D, red bars) mice injected with CL316,243. e, H&E
staining of sWAT from sham-operated and cBAT-denervated mice after CL316,243-
injections. All data are presented as mean ± s.e.m (n=4). Asterisks denote significant
differences between denervation and respective control groups: * P < 0.05 as determined by
ANOVA.
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